| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.22 | 0.009 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |